Healthcare Triangle, Inc. (NASDAQ:HCTI)  shares are trending on Thursday.

HCTI shares jumped 36.64% in after-hours trading on Wednesday, climbing to $3.99, after the California-based company announced it had deployed Agentic AI into Teyame.AI's customer engagement platform.

The deployment comes after HCTI completed its $50 million acquisition in January of Teyamé 360 S.L. and Datono Mediación S.L., the two Spanish companies behind the Teyame platform, through its subsidiary Teyame AI Holdings Inc.

AI platform targets a $199B market opportunity

According to data from Precedence Research cited by Healthcare Triangle, the global agentic AI market is expected to grow from $7.5 billion in 2025 to $199.05 billion by 2034, representing a 45% compound annual growth rate. Precedence Research also notes 60% of enterprises are expected to integrate agentic AI into core processes by 2030.

HCTI’s platform targets this growth with automated outbound voice agents, real-time lead scoring, and multilingual omnichannel handoffs built for healthcare compliance.

The health information technology company stated that, building on Teyamé’s existing footprint in Spain, HCTI is scaling the platform across the U.S. and Latin America.

SaaS Expansion into Payors and Financial Services

The deal supports HCTI’s broader strategy, which includes global SaaS platforms and expansion beyond healthcare into payors and financial services.

Chief Financial Officer David Ayanoglou said the company is “at the cutting edge of Agentic AI integration” and expects to accelerate growth over the next few years.

Trading Metrics, Technical Analysis

Healthcare Triangle has a market capitalization of $3.37 million. It has a Relative Strength Index (RSI) of 25.10.

Over the past 12 months, the stock has dropped 99.94%.

HCTI is currently trading very close to its 52-week low.

The steep decline and its position near the annual low highlight significant pressure, signaling high risk and the need for clear recovery signals before investor confidence can return.

Price Action: According to Benzinga Pro data, HCTI closed the regular session at $2.92, up 11.45%.

Benzinga's Edge Stock Rankings indicate HCTI stock has a negative price trend across all time frames.

Photo Courtesy: SuPatMaN on Shutterstock.com

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.